Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2025-12-24 @ 5:06 PM
NCT ID:
NCT00148850
Eligibility Criteria:
Inclusion Criteria:
* 18 years of ages and older
* Confirmed laboratory diagnosis of HIV-1-infection
* Karnofsky equal or over 70%
* Patients treated with stable antiretroviral therapy for at least 6 months
* Plasma viral load below 400 copies/ ml and CD4 count over 200/mm3 for at least 6 months
* Patients with a clinical peripheral lipoatrophy self reported by the patient and confirmed by physical examination
Exclusion Criteria:
* Cachexia
* Cardiac failure class3 or 4 at NYHA classification
* Acute opportunistic infection
* Pregnancy or breast-feeding
* Polynuclear neutrophils below 1000/mm3
* Hemoglobin below 9 g/dl
* Platelets below 50 000/mm3
* Creatinine level over 2 UN
* ASAT, ALAT over 2.5UN
* Bilirubin, amylase, lipase level over 2 UN
* CD4 count below 200/mm3
* Patients treated by any antidiabetic or lipid lowering drugs, anabolic or corticosteroid hormone
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00148850
Study Brief:
Protocol Section:
NCT00148850